62 related articles for article (PubMed ID: 8806794)
1. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF
Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794
[TBL] [Abstract][Full Text] [Related]
2. MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.
Kim TS; Cohen EP
Cancer Immunol Immunother; 1994 Mar; 38(3):185-93. PubMed ID: 8124687
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma.
Pulaski BA; Clements VK; Pipeling MR; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2000 Apr; 49(1):34-45. PubMed ID: 10782864
[TBL] [Abstract][Full Text] [Related]
4. The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model.
Labarthe MC; Halanek N; Birchall L; Russell N; Desel C; Todryk S; Peters MJ; Lucas A; Falkenberg FW; Dalgleish AG; Whelan M; Ward SJ
Cancer Immunol Immunother; 2006 Mar; 55(3):277-88. PubMed ID: 16158275
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro.
Fujimoto T; O'Donnell MA; Szilvasi A; Yang H; Duda RB
Cancer Immunol Immunother; 1996 Jun; 42(5):280-4. PubMed ID: 8706049
[TBL] [Abstract][Full Text] [Related]
6. Immuno-gene therapy of melanoma by tumor antigen epitope modified IFN-gamma.
He X; Luo P; Tsang TC; Zhang T; Harris DT
Cancer Immunol Immunother; 2005 Aug; 54(8):741-9. PubMed ID: 15726359
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous interleukin-15 inducibilities in murine B16 melanoma and RM-1 prostate carcinoma by interferon-alpha treatment.
Wu TG; Perdigão JR; Umhoefer TK; Cao J; Ansari DA; Albrecht TB; Knutson EP; Rose WA; Jorgensen AJ; Ryan LM; Abdalla LE; Fleischmann WR
J Interferon Cytokine Res; 2009 Nov; 29(11):719-28. PubMed ID: 19642895
[TBL] [Abstract][Full Text] [Related]
8. TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect.
Penafuerte C; Galipeau J
Cancer Immunol Immunother; 2008 Aug; 57(8):1197-206. PubMed ID: 18214474
[TBL] [Abstract][Full Text] [Related]
9. Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A.
Shrayer DP; Kouttab N; Hearing VJ; Wanebo HJ
Cancer Immunol Immunother; 1998 Mar; 46(1):7-13. PubMed ID: 9520286
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge.
Mazorra Z; Mesa C; Fernández A; Fernández LE
Cancer Immunol Immunother; 2008 Dec; 57(12):1771-80. PubMed ID: 18351335
[TBL] [Abstract][Full Text] [Related]
11. Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking.
Eisenthal A; Ramakrishna V; Skornick Y; Shinitzky M
Cancer Immunol Immunother; 1993 May; 36(5):300-6. PubMed ID: 8477416
[TBL] [Abstract][Full Text] [Related]
12. Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells.
Li B; Lei Z; Lichty BD; Li D; Zhang GM; Feng ZH; Wan Y; Huang B
Cancer Immunol Immunother; 2010 Feb; 59(2):313-21. PubMed ID: 19680649
[TBL] [Abstract][Full Text] [Related]
13. Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice.
Lasek W; Basak G; Switaj T; Jakubowska AB; Wysocki PJ; Mackiewicz A; Drela N; Jalili A; Kamiński R; Kozar K; Jakóbisiak M
Cancer Immunol Immunother; 2004 Apr; 53(4):363-72. PubMed ID: 14605763
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer of a hybrid interleukin-1 beta gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo.
Björkdahl O; Wingren AG; Hedhund G; Ohlsson L; Dohlsten M
Cancer Immunol Immunother; 1997 Jul; 44(5):273-81. PubMed ID: 9247562
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of immune-inflammatory regulation in Tremella fuciformis-derived polysaccharide reeducated B16 cells: A subcutaneous model.
Li X; Su Q; Pan Y
Adv Clin Exp Med; 2024 May; 33(5):533-542. PubMed ID: 38775333
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 secretion by KHT sarcoma cells leads to loss of their vaccine potential.
Hsu SC; Glaves D; Sood AK
Cancer Immunol Immunother; 1997 Apr; 44(2):117-24. PubMed ID: 9177474
[TBL] [Abstract][Full Text] [Related]
17. Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.
Ramakrishna V; Eisenthal A; Skornick Y; Shinitzky M
Cancer Immunol Immunother; 1993 May; 36(5):293-9. PubMed ID: 8477415
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenicity of interleukin-2 (IL-2)-cDNA-transfected L1210 lymphoma and its in vivo variants is modulated by changes in IL-2 expression; potential therapeutic implications.
Chakravarty PK; Fuji H; Abu-Hadid MM; Hsu SC; Sood AK
Cancer Immunol Immunother; 1992; 35(5):347-54. PubMed ID: 1394339
[TBL] [Abstract][Full Text] [Related]
19. High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function.
Pizzurro GA; Madorsky Rowdo FP; Pujol-Lereis LM; Quesada-Allué LA; Copati AM; Roberti MP; Teillaud JL; Levy EM; Barrio MM; Mordoh J
Cancer Immunol Immunother; 2013 Jan; 62(1):3-15. PubMed ID: 22722447
[TBL] [Abstract][Full Text] [Related]
20. Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity.
Garrido C; Algarra I; Maleno I; Stefanski J; Collado A; Garrido F; Garcia-Lora AM
Cancer Immunol Immunother; 2010 Jan; 59(1):13-26. PubMed ID: 19430787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
